Antiviral activity of selected flavonoids against Chikungunya virus

Antiviral Research

Volumn 133, Issue , 2016, Pages 50-61

  Lani, Rafidah ^a   Hassandarvish, Pouya ^a   Shu, Meng Hooi ^a   Phoon, Wai Hong ^a   Chu, Justin Jang Hann ^b   Higgs, Stephen ^c   Vanlandingham, Dana ^c   Abu Bakar, Sazaly ^a   Zandi, Keivan ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c KANSAS STATE UNIVERSITY   (United States)

Author keywords

Antiviral effect; Chikungunya virus; Flavonoids; Natural compounds

Indexed keywords

BAICALEIN; FISETIN; FLAVONOID; QUERCETAGETIN; UNCLASSIFIED DRUG; VIRUS RNA; ANTIVIRUS AGENT; BIOLOGICAL PRODUCT;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CHIKUNGUNYA; CHIKUNGUNYA VIRUS; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; CYTOTOXICITY ASSAY; DRUG SCREENING; EXTRACELLULAR MATRIX; IC50; IMMUNOFLUORESCENCE TEST; NONHUMAN; PRIORITY JOURNAL; REPLICON CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA REPLICATION; VERO CELL LINE; VIRUS ATTACHMENT; VIRUS ENTRY; VIRUS INACTIVATION; VIRUS PARTICLE; WESTERN BLOTTING; ANIMAL; CELL LINE; CHEMISTRY; DOSE RESPONSE; DRUG EFFECTS; GENETICS; GENOTYPE; HAMSTER; PRECLINICAL STUDY; VIRUS REPLICATION;

ANIMALS; ANTIVIRAL AGENTS; BIOLOGICAL PRODUCTS; CELL LINE; CHIKUNGUNYA VIRUS; CRICETINAE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; FLAVONOIDS; GENOTYPE; INHIBITORY CONCENTRATION 50; VERO CELLS; VIRUS REPLICATION;

EID: 84979944502     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2016.07.009     Document Type: Article

References (35)

1. Ahmed-Belkacem, A., Guichou, J.F., Brillet, R., Ahnou, N., Hernandez, E., Pallier, C., Pawlotsky, J.M., Inhibition of RNA binding to hepatitis C virus RNA-dependent RNA polymerase: a new mechanism for antiviral intervention. Nucleic Acids Res. 42 (2014), 9399–9409.
2. Alfaro-Toloza, P., Clouet-Huerta, D.E., Rodriguez-Morales, A.J., Chikungunya, the emerging migratory rheumatism. Lancet Infect. Dis. 15 (2015), 510–512.
3. Bonn, D., How did chikungunya reach the Indian Ocean?. Lancet Infect. Dis., 6, 2006, 543.
4. Briolant, S., Garin, D., Scaramozzino, N., Jouan, A., Crance, J.M., In vitro inhibition of Chikungunya and Semliki Forest viruses replication by antiviral compounds: synergistic effect of interferon-α and ribavirin combination. Antivir. Res. 61 (2004), 111–117.
5. Centers For Disease Control And Prevention, CDC Health Information for International Travel 2016. 2015, Oxford University Press.
6. Chiam, C.W., Chan, Y.F., Loong, S.K., Yong, S.S.J., Hooi, P.S., Sam, I.C., Real-time polymerase chain reaction for diagnosis and quantitation of negative strand of chikungunya virus. Diagn. Microbiol. Infect. Dis. 77 (2013), 133–137.
7. Cotin, S., Calliste, C.A., Mazeron, M.C., Hantz, S., Duroux, J.L., Rawlinson, W.D., Ploy, M.-C., Alain, S., Eight flavonoids and their potential as inhibitors of human cytomegalovirus replication. Antivir. Res. 96 (2012), 181–186.
8. Daelemans, D., Pauwels, R., De Clercq, E., Pannecouque, C., A time-of-drug addition approach to target identification of antiviral compounds. Nat. Protoc. 6 (2011), 925–933.
9. de Lamballerie, X., Leroy, E., Charrel, R.N., Ttsetsarkin, K., Higgs, S., Gould, E.A., Chikungunya virus adapts to tiger mosquito via evolutionary convergence: a sign of things to come?. Virology, 5, 2008, 33.
10. de Lamballerie, X., Ninove, L., Charrel, R.N., Antiviral treatment of chikungunya virus infection. Infect. Disord. Drug Targets 9 (2009), 101–104.
11. Delogu, I., Pastorino, B., Baronti, C., Nougairède, A., Bonnet, E., de Lamballerie, X., In vitro antiviral activity of arbidol against Chikungunya virus and characteristics of a selected resistant mutant. Antivir. Res. 90 (2011), 99–107.
12. Farshadpour, F., Gharibi, S., Taherzadeh, M., Amirinejad, R., Taherkhani, R., Habibian, A., Zandi, K., Antiviral activity of Holothuria sp. a sea cucumber against herpes simplex virus type 1 (HSV-1). Eur. Rev. Med. Pharmacol. Sci. 18 (2014), 333–337.
13. Garcia-Mediavilla, V., Crespo, I., Collado, P.S., Esteller, A., Sanchez-Campos, S., Tunon, M.J., Gonzalez-Gallego, J., The anti-inflammatory flavones quercetin and kaempferol cause inhibition of inducible nitric oxide synthase, cyclooxygenase-2 and reactive C-protein, and down-regulation of the nuclear factor kappa B pathway in Chang Liver cells. Eur. J. Pharmacol. 557 (2007), 221–229.
14. Gérardin, P., Barau, G., Michault, A., Bintner, M., Randrianaivo, H., Choker, G., Lenglet, Y., Touret, Y., Bouveret, A., Grivard, P., Le Roux, K., Blanc, S., Schuffenecker, I., Couderc, T., Arenzana-Seisdedos, F., Lecuit, M., Robillard, P.-Y., Multidisciplinary prospective study of mother-to-child chikungunya virus infections on the island of La Réunion. PLoS Med., 5, 2008, e60, 10.1371/journal.pmed.0050060.
15. Higgs, S., Vanlandingham, D.L., Chikungunya: here today, where tomorrow?. Int. Health 7 (2015), 1–3.
16. Johnston, R.E., Peters, C., Fields, B.N., Knipe, D.M., Howly, P.M., (eds.) Alphaviruses Associated Primarily with Fever and Polyarthritis, 1996, Raven Press, New York.
17. Kaur, P., Thiruchelvan, M., Lee, R.C.H., Chen, H., Chen, K.C., Ng, M.L., Chu, J.J.H., Inhibition of Chikungunya virus replication by Harringtonine, a novel antiviral that suppresses viral protein expression. Antimicrob. Agents Chemother. 57 (2013), 155–167.
18. Khan, M., Dhanwani, R., Patro, I.K., Rao, P.V., Parida, M.M., Cellular IMPDH enzyme activity is a potential target for the inhibition of chikungunya virus replication and virus induced apoptosis in cultured mammalian cells. Antivir. Res. 89 (2011), 1–8.
19. Lin, Y.J., Chang, Y.C., Hsiao, N.W., Hsieh, J.L., Wang, C.Y., Kung, S.H., Tsai, F.J., Lan, Y.C., Lin, C.W., Fisetin and rutin as 3C protease inhibitors of enterovirus A71. J. Virol. Methods 182 (2012), 93–98.
20. Moghaddam, E., Teoh, B.T., Sam, S.S., Lani, R., Hassandarvish, P., Chik, Z., Yueh, A., Abubakar, S., Zandi, K., Baicalin, a metabolite of baicalein with antiviral activity against dengue virus. Sci. Rep., 4, 2014.
21. Pohjala, L., Utt, A., Varjak, M., Lulla, A., Merits, A., Ahola, T., Tammela, P., Inhibitors of alphavirus entry and replication identified with a stable Chikungunya replicon cell line and virus-based assays. PLoS One, 6, 2011, e28923.
22. Powers, A.M., Brault, A.C., Tesh, R.B., Weaver, S.C., Re-emergence of chikungunya and o'nyong-nyong viruses: evidence for distinct geographical lineages and distant evolutionary relationships. J. Gen. Virol. 81 (2000), 471–479.
23. Queyriaux, B., Simon, F., Grandadam, M., Michel, R., Tolou, H., Boutin, J.P., Clinical burden of chikungunya virus infection. Lancet Infect. Dis. 8 (2008), 2–3.
24. Ravichandran, R., Manian, M., Ribavirin therapy for Chikungunya arthritis. J. Infect. Dev. Ctries. 2 (2008), 140–142.
25. Reed, L.J., Muench, H., A simple method of estimating fifty per cent endpoints. Am. J. Epidemiol. 27 (1938), 493–497.
26. Rodriguez-Morales, A.J., Cardona-Ospina, J.A., Villamil-Gómez, W., Paniz-Mondolfi, A.E., How many patients with post-chikungunya chronic inflammatory rheumatism can we expect in the new endemic areas of Latin America?. Rheumatol. Int. 35 (2015), 2091–2094.
27. Shimizu, Y., Yamamoto, S., Homma, M., Ishida, N., Effect of chloroquine on the growth of animal viruses. Arch. Gesamte Virusforsch 36 (1972), 93–104.
28. Singh, R.P., Gu, M., Argawal, R., Silibinin inhibits colorectal cancer growth by inhibiting tumor cell proliferation and angiogenesis. Cancer Res. 68 (2008), 2043–2050.
29. Smith, D.W., Mackenzie, J.S., Weaver, S.C., Alphaviruses. Richman, D.D., Whitley, R.J., Hayden, F.G., (eds.) Clinical Virology, 2009, ASM Press, 1241–1274.
30. Sung, B., Pandey, M.K., Aggarwal, B.B., Fisetin, an inhibitor of cyclin-dependent kinase 6, down-regulates nuclear factor-kappa B-regulated cell proliferation, antiapoptotic and metastatic gene products through the suppression of TAK-1 and receptor-interacting protein-regulated I kappa B alpha kinase activation. Mol. Pharmacol. 71 (2007), 1703–1714.
31. Tapas, A.R., Sakarkar, D.M., Kakde, R.B., Flavonoids as nutraceuticals: a review. Trop. J. Pharm. Res. 7 (2008), 1089–1099.
32. Tsetsarkin, K.A., Chen, R., Sherman, M.B., Weaver, S.C., Chikungunya virus: evolution and genetic determinants of emergence. Curr. Opin. Virol. 1 (2011), 310–317.
33. Williams, R.J., Spencer, J.P.E., Rice-Evans, C., Flavonoids: anti-oxidants or signaling molecules?. Free Radic. Biol. Med. 36 (2004), 838–849.
34. Zandi, K., Teoh, B.T., Sam, S.S., Wong, P.F., Mohd Rais, M., AbuBakar, S., In vitro antiviral activity of fisetin, rutin and naringenin against dengue virus type-2. J. Med. Plant Res. 5 (2011), 5534–5539.
35. Zandi, K., Teoh, B.T., Sam, S.S., Wong, P.F., Mustafa, M.R., AbuBakar, S., Novel antiviral activity of baicalein against dengue virus. BMC Complement. Altern. Med., 12, 2012, 214.